Daewoong to patent pravastatin composite for prolonged efficacy.

Daewoong announced that a composite of sodium pravastatin with co-polyvidon was patent registered for the improvement of its stability and thereby prolonged efficacy characterized in which co-polividon protect pravastatin from hydration.

Daewoong said that the pilot product test already completed and obtained the KFDA approval under the brandname of "Starpra tab." currently selling at about ...